SCHEMBL19320153

SCHEMBL19320153

c1ccc2c(-n3c4ccccc4c4cc5c(cc43)sc3cc4c(cc35)[nH]c3ccccc34)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.41
▸ TOP2A P11388 1/20 0.34
▸ KIF11 P52732 5/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GPR3 P46089 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ GSK3A P49840 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ CNR1 P21554 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ HCAR1 Q9BXC0 2/20 0.31
▸ MAPT P10636 2/20 0.30
▸ HTR6 P50406 1/20 0.30
▸ TNKS O95271 1/20 0.30
▸ TNKS2 Q9H2K2 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ ATM Q13315 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19320157 0.94 TDP1 (0.39) AHRTOP2AKIF11ALDH1A1HSD17B10
SCHEMBL21942166 0.88 AHR (0.50) AHRTOP2AKIF11ALDH1A1GPR3
SCHEMBL17246472 0.85 GPR3 (0.39) ALDH1A1GPR3HSD17B10GSK3AGSK3B
SCHEMBL19320144 0.84 AHR (0.38) AHRTOP2AKIF11ALDH1A1GPR3
SCHEMBL17759688 0.84 CDK4 (0.31) AHRGSK3AGSK3B
SCHEMBL19325029 0.84 CDK4 (0.36) AHRGSK3AGSK3B
SCHEMBL19320110 0.84 MEN1 (0.41) KIF11GSK3AGSK3BMAPTTNKS
SCHEMBL17548853 0.84 KIF11 (0.40) KIF11GSK3AGSK3BCNR1CNR2
SCHEMBL19320151 0.83 KDM4E (0.45) AHRTOP2AKIF11ALDH1A1GPR3
SCHEMBL19320152 0.83 AHR (0.40) AHRTOP2AKIF11ALDH1A1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10381574-B2 Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2019-08-13 — — US disclosed
US-20190103561-A1 Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same DUK SAN NEOLUX CO., LTD (KR) 2019-04-04 — — US disclosed
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME ORAI2, VDAC2, PIEZO1 AHR 765/4885TOP2A 3352/4885KIF11 3968/4885
US-20190103561-A1 Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same ORAI2, VDAC2, PIEZO1 AHR 765/4885TOP2A 3352/4885KIF11 3968/4885
US-10381574-B2 Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same ORAI2, VDAC2, PIEZO1 AHR 765/4885TOP2A 3352/4885KIF11 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback